Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Medicare Advantage insurers could face an average 2.3% cut to payments in 2024, or a net cut of more than $3 billion, if the government proposal stands. → Read More
A new rule will give a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. → Read More
The rule, part of a decade-long feud between the health insurance industry and regulators, will likely invite lawsuits from industry groups. → Read More
A decade-long battle over Medicare Advantage audits is coming to a head as Medicare makes a final determination about industry oversight. → Read More
Usually, the RAC acronym elicits rage in hospital circles. But another kind — regional advisory councils — helped subsidize some hospitals during Covid. → Read More
Hospitals’ message at #JPM23: This year will be about increasing revenue by expanding footprints and hiking prices. → Read More
“Profitability is the number one goal” for this year, Oscar CEO Mario Schlosser told STAT in an interview at #JPM23. → Read More
Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public. All three said at #JPM23 that the drastic changes they’ve made should bring profitability. → Read More
Rising labor costs have been the main financial concern for hospitals over the past year, but those costs have peaked and are now a lot lower, according to hospital system executives at #JPM23. → Read More
STAT's @bobjherman and @TaraBannow lay out which health care providers and insurance companies they'll be watching at #JPM23. → Read More
STAT’s business reporters will be paying attention to three hospital and insurance trends next year. Read about them here. → Read More
Curative's Covid-19 test business is now firmly in the past. The company has switched to an even more regulated industry: health insurance. → Read More
Medicare is willing to reevaluate its coverage of Alzheimer’s drugs in light of a new therapy, called lecanemab, that has shown potentially more promising patient data, the CMS director said Thursday. → Read More
For cancer patients who must make frequent trips for treatments like radiation and chemotherapy, the cost of daily parking fees adds up. → Read More
The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor. → Read More
Consumer groups are demanding the government enforce a new law that requires providers and insurers to give patients price and cost estimates before they get care, when possible. → Read More
The stock price of R1 RCM tanked by roughly 50% this week after the large medical billing and collections company reported an unexpected $30 million loss in the third quarter. → Read More
Medicare unleashed an avalanche of regulations this past week, and there was a subtle theme: Don’t rock the boat too much for seniors, a crucial voting bloc in this week’s midterm elections. → Read More
The federal government is officially reducing Medicare payments to physicians next year by 4.5%, but doctors and their lobbyists are ready to blitz Congress to avert the cuts. → Read More
Welsh Carson paints itself as nobler than other private equity firms. STAT’s special report on its investment strategy reveals a relentless pursuit of profits — one that can come at the expense of patients and taxpayers. → Read More